Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905148-24-002838
Filing Date
2024-10-25
Accepted
2024-10-25 16:23:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 sayw24111406_13ga.htm SC 13G/A 95170
  Complete submission text file 0000905148-24-002838.txt   96998
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50118 | Film No.: 241397348
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 3033 EXCELSIOR BLVD. SUITE 500 MINNEAPOLIS MN 55416
Business Address 3033 EXCELSIOR BLVD. SUITE 500 MINNEAPOLIS MN 55416 612-253-6001
WHITEBOX ADVISORS LLC (Filed by) CIK: 0001257391 (see all company filings)

EIN.: 411957584 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A